Hepatitis C and hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Infectious Diseases

Background:

• Chronic Hepatitis C virus (HCV) infection is a known risk factor for hepatocellular carcinoma (HCC).
• The prevalence and etiological contribution of HCV to HCC vary geographically.
• Cirrhosis is a key factor amplifying HCC risk in HCV-infected individuals.

Purpose of the Study:

• To summarize the evidence linking chronic HCV infection to HCC risk.
• To analyze the geographical distribution of HCV-related HCC.
• To compare the role of HCV versus other etiologies in HCC development.

Main Methods:

• Systematic review of existing epidemiological and clinical evidence.
• Analysis of HCC incidence data stratified by etiology and region.
• Comparative assessment of risk factors for HCC.

Main Results:

• Strong evidence confirms that chronic HCV infection substantially increases HCC risk, particularly when cirrhosis is present.
• HCV is a primary cause of HCC in regions with intermediate incidence like Southern Europe and Japan.
• HCV's contribution to HCC is less prominent in regions dominated by Hepatitis B virus (HBV) or where HCC is often linked to unknown cirrhotic causes.

Conclusions:

• Chronic HCV infection is a significant global driver of hepatocellular carcinoma.
• Geographical and etiological factors, including HBV and cirrhosis of unknown origin, modulate the impact of HCV on HCC.
• Understanding these variations is crucial for targeted HCC prevention and management strategies.